Skip to main content

Page of 18
and
  1. Article

    Open Access

    FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer

    Ovarian cancer is one of the most common gynecological malignancies due to the lack of early symptoms, early diagnosis and limited screening. Therefore, it is necessary to understand the molecular mechanism un...

    Gendi Song, Zhengwei Sun, Man Chu, Zihan Zhang, Jiajia Chen, Zhiwei Wang in BMC Cancer (2024)

  2. No Access

    Protocol

    Patient-Derived Xenograft Models for Ovarian Cancer

    Patient-derived xenograft (PDX) models play a crucial role for in vivo research. They maintain the original molecular characteristics of the human tumor and provide a more accurate tumor microenvironment, whic...

    Trang Minh Tran, Gwo Yaw Ho, Simon Chu in Patient-Derived Xenografts (2024)

  3. No Access

    Article

    The dynamic role of platelets in cancer progression and their therapeutic implications

    Systemic antiplatelet treatment represents a promising option to improve the therapeutic outcomes and therapeutic efficacy of chemotherapy and immunotherapy due to the critical contribution of platelets to tum...

    Su** Li, Zefang Lu, Suying Wu, Tianjiao Chu, Bozhao Li in Nature Reviews Cancer (2024)

  4. Article

    Open Access

    Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study

    To investigate the predictive value of baseline C-reactive protein (CRP) levels on the efficacy of chemotherapy plus immune checkpoint inhibitors (ICI) in patients with advanced lung squamous cell carcinoma (L...

    **nlong Zheng, Longfeng Zhang, Lin Wu, Jun Zhao, Jianguo Sun, Yong Fang in BMC Cancer (2023)

  5. Article

    Open Access

    Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database

    Multiple myeloma (MM) remains incurable despite the availability of novel agents. This multi-center retrospective cohort study used the Canadian Myeloma Research Group Database to describe real-world outcomes ...

    A. Visram, A. De La Torre, D. White, J. Su, E. Masih-Khan, M. Chu in Blood Cancer Journal (2023)

  6. Article

    Open Access

    Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial

    Multiple myeloma (MM) is a plasma cell malignancy expressing B cell maturation antigen (BCMA). Elranatamab, a bispecific antibody, engages BCMA on MM and CD3 on T cells. The MagnetisMM-1 trial evaluated its sa...

    Nizar J. Bahlis, Caitlin L. Costello, Noopur S. Raje, Moshe Y. Levy in Nature Medicine (2023)

  7. Article

    Open Access

    Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database

    Autologous stem cell transplant (ASCT) remains an important option for eligible multiple myeloma (MM) patients as part of initial therapy. Using the Canadian Myeloma Research Group (CMRG) national database, we...

    Julie Côté, Richard LeBlanc, Hira Mian, Michael P. Chu in Blood Cancer Journal (2023)

  8. No Access

    Article

    The composition and roles of gastric stem cells in epithelial homeostasis, regeneration, and tumorigenesis

    The epithelial lining of the stomach undergoes rapid turnover to preserve its structural and functional integrity, a process driven by long-lived stem cells residing in the antral and corpus glands. Several su...

    Meng Liu, Qin Liu, Qiang Zou, **yang Li, Zhaole Chu, Junyu **ang in Cellular Oncology (2023)

  9. No Access

    Article

    Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells

    Cetuximab, an epidermal growth factor receptor (EGFR) inhibitor, is extensively used for clinical therapy in KRAS wild-type colorectal cancer (CRC) patients. However, some patients still cannot get benefit fro...

    Yongming Lv, Wenhong Wang, Yanfei Liu, Ben Yi in Clinical & Experimental Metastasis (2023)

  10. Article

    Open Access

    Role of SH3GLB1 in the regulation of CD133 expression in GBM cells

    Glioblastoma (GBM), a malignant brain tumor, has poor survival outcomes due to recurrence or drug resistance. We found that SH3GLB1 is a crucial factor for cells to evade temozolomide (TMZ) cytotoxicity throug...

    Chia-Hung Chien, Chien-Cheng Lai, Jian-Ying Chuang, Jui-Mei Chu in BMC Cancer (2023)

  11. No Access

    Article

    CircRNA7632 down-regulation alleviates endothelial cell dysfunction in Kawasaki disease via regulating IL-33 expression

    Kawasaki disease (KD) is a form of idiopathic vasculitis frequently accompanied by coronary artery lesions, which involves endothelial dysfunction. Recent studies have demonstrated that circular RNAs (circRNAs...

    Huixian Qiu, Chao Ni, Chang Jia, **ng Rong, Mao** Chu in Cell Stress and Chaperones (2023)

  12. Article

    Open Access

    EBV antibody and gastric cancer risk: a population-based nested case-control study in southern China

    We aim to clarify the controversial associations between EBV-related antibodies and gastric cancer risk.

    Yun Du, **a Yu, Ellen T. Chang, Li Yin, Shifeng Lian, Biaohua Wu, Fugui Li in BMC Cancer (2023)

  13. Article

    Open Access

    A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models

    Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer and is notorious for its resistance to both chemotherapy and small-molecule inhibitor targeted therapies. Subcellular targeted c...

    Stefan Mrdenovic, Yan** Wang, Lijuan Yin, Gina Chia-Yi Chu, Yan Ou in BMC Cancer (2023)

  14. No Access

    Article

    Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

    Tumor-infiltrating T cells offer a promising avenue for cancer treatment, yet their states remain to be fully characterized. Here we present a single-cell atlas of T cells from 308,048 transcriptomes across 16...

    Yanshuo Chu, Enyu Dai, Yating Li, Guangchun Han, Guangsheng Pei in Nature Medicine (2023)

  15. No Access

    Article

    Risk factors for endometrial cancer in Black women

    The incidence of endometrial cancer (EC) has been increasing faster among Black women than among other racial/ethnic groups in the United States. Although the mortality rate is nearly twice as high among Black...

    Todd R. Sponholtz, Julie R. Palmer, Lynn Rosenberg, Chu Chen in Cancer Causes & Control (2023)

  16. Article

    Open Access

    The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level

    Newcastle disease virus (NDV) is an oncolytic virus that can inhibit cancer cell proliferation and kill cancer cells. The NDV nonstructural V protein can regulate viral replication; however, whether the V prot...

    Zhili Chu, Sihui Yang, Qianru Li, Jianing Shang, Zilong Ren, Feng Ren in BMC Cancer (2023)

  17. Article

    Correction to: Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis

    Ying Xu, Guangchao Luan, Zhongchao Li, Ziming Liu, Guangyang Qin in Cellular Oncology (2023)

  18. No Access

    Article

    Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis

    Hepatocellular carcinoma (HCC) cell-derived exosomal LncRNA SNHG16 is highly expressed and associated with poor overall survival of patients. Telocytes (TCs), as novel interstitial cells, have been reported to...

    Ying Xu, Guangchao Luan, Zhongchao Li, Ziming Liu, Guangyang Qin in Cellular Oncology (2023)

  19. No Access

    Article

    TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling

    Gastric cancer is a gastrointestinal malignancy with high mortality and poor prognosis, and the molecular mechanism of gastric tumorigenesis remains unclear. TRIM44 has been reported to be involved in tumor de...

    **n Zhang, **usheng Wu, Ying Sun, Yali Chu, Fengjun Liu, Cheng Chen in Cellular Oncology (2023)

  20. Article

    Open Access

    PTBP1 drives c-Myc-dependent gastric cancer progression and stemness

    Gastric cancer (GC) tumorigenesis and treatment failure are caused by cancer stem cells. Polypyrimidine tract binding protein 1 (PTBP1) was shown to be involved in the development of embryonic stem cells and i...

    Tengyang Ni, Zewen Chu, Li Tao, Yang Zhao, Miao Zhu in British Journal of Cancer (2023)

Page of 18